Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

121.16 -10.58 (-8.03%)
Streaming Delayed Price Updated: 2:24 PM EDT, Jul 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
46 47 Next >
P/E Ratio Insights for Abbott Laboratories
Via Benzinga
Why Abbott Laboratories (ABT) Shares Are Plunging Today
Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.1% in the afternoon session after the company reported second-quarter earnings that beat analyst expectations but... 
Via StockStory
Unusual volume S&P500 stocks in Thursday's session
Let's have a look at the S&P500 stocks with an unusual volume in today's session. 
Via Chartmill
Nasdaq 100 Sets New Records, Small Caps Outperform: What's Moving Markets Thursday?
U.S. equities climbed on Thursday, with the S&P 500 briefly testing a record high 6,300 level at midday in New York, bolstered by strong earnings and upbeat retail sales data that reinforced investor... 
Via Benzinga
A Preview Of Abbott Laboratories's Earnings
Via Benzinga
Abbott Reports 10.5% EPS Growth for Fiscal Q2
Via The Motley Fool
Topics Economy World Trade
Stay informed with the top movers within the S&P500 index on Thursday.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session. 
Via Chartmill
Abbott (ABT) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors
Abbott posted Q2 revenue of $11.14 billion and EPS of $1.26, raised 2025 earnings guidance, and saw strong growth in diabetes and heart device sales. 
Via Benzinga
Which S&P500 stocks are gapping on Thursday?
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
Abbott Stock Slips On Disappointing Q3 Earnings Forecast: Retail Chatter Rises Over 200% In 24 Hours
Abbott’s sales of continuous glucose monitors were $1.9 billion in the second quarter, marking a growth of 21.4% on a reported basis, the company said. 
Via Stocktwits
Topics Artificial Intelligence
Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Miss
The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts. 
Via Investor's Business Daily
Topics Government Stocks
Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Wondering what's happening in today's S&P500 pre-market session?
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers. 
Via Chartmill
Dow Futures Edge Lower As Trump, Powell Feud Escalates, Earnings Take Centerstage: TSMC, PEP, UAL, GE Among Stocks To Watch
While Dow Jones futures were down 0.12% at the time of writing, the S&P 500 futures were up 0.06%. 
Via Stocktwits
Topics ETFs Economy Government
Abbott Laboratories’s (NYSE:ABT) Q2 Sales Top Estimates
Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of... 
Via StockStory
Earnings Scheduled For July 17, 2025
Via Benzinga
Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
Nvidia To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Abbott Laboratories (ABT) Q2 Earnings: What To Expect
Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results this Thursday morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Meta To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ABT),(NASDAQ:DXCM),(NASDAQ:IRTC),(NASDAQ:TNDM) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
3 Profitable Stocks to Research Further
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline. 
Via StockStory
Topics Economy Supply Chain
3 Dividend Growth Stocks to Buy and Hold
Via The Motley Fool
Topics Intellectual Property
Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Abbott Laboratories Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
Via Benzinga
2 Dividend Stocks to Buy for Decades of Passive Income
Via The Motley Fool
Topics Intellectual Property
1 S&P 500 Stock to Research Further and 2 to Keep Off Your Radar
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process. 
Via Investor's Business Daily
Got $500? 2 Healthcare Stocks to Buy and Hold Forever
Via The Motley Fool
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
46 47 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.